Cumulative amount of intravenous lipid intake and parenteral nutrition-associated cholestasis in neonates with gastrointestinal surgical disorders

American Journal of Perinatology

Volumn 31, Issue 5, 2014, Pages 419-424

  Nayrouz, Mazen M ^a   Amin, Sanjiv B ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

direct hyperbilirubinemia; hepatic dysfunction; late preterm neonates; lipid

Indexed keywords

AMINOTRANSFERASE; CHOLECYSTOKININ; GLUCOSE; LIPID; PROTEIN; URSODEOXYCHOLIC ACID; PARENTERAL SOLUTION;

ARTICLE; BILIARY TRACT MALFORMATION; CHOLESTASIS; CHROMOSOME DISORDER; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SURGICAL DISORDER; GESTATIONAL AGE; GLUCOSE INTAKE; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; HYPERBILIRUBINEMIA; LIVER DISEASE; MALE; METABOLIC DISORDER; NEWBORN; PARENTERAL NUTIRTION ASSOCIATED CHOLESTASIS; PARENTERAL NUTRITION; PARVOVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN INTAKE; RETROSPECTIVE STUDY; RUBELLA; SYPHILIS; TOXOPLASMOSIS; CHEMISTRY; COHORT ANALYSIS; GASTROSCHISIS; HERNIA, UMBILICAL; PATHOPHYSIOLOGY; PREMATURITY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

CHOLESTASIS; COHORT STUDIES; FEMALE; GASTROSCHISIS; GESTATIONAL AGE; GLUCOSE; HERNIA, UMBILICAL; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LIPIDS; LOGISTIC MODELS; MALE; PARENTERAL NUTRITION; PARENTERAL NUTRITION SOLUTIONS; PROTEINS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 84899975450     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0033-1352481     Document Type: Article

References (37)

1. Klein C. J., Revenis M., Kusenda C., Scavo L. Parenteral nutrition-associated conjugated hyperbilirubinemia in hospitalized infants. J Am Diet Assoc: 2010; 110 11 1684 1695
2. Willis T. C., Carter B. A., Rogers S. P., Hawthorne K. M., Hicks P. D., Abrams S. A. High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr: 2010; 34 1 32 37
3. Suchy F. J. Neonatal cholestasis. Pediatr Rev: 2004; 25 11 388 396
4. Colomb V., Jobert-Giraud A., Lacaille F., Goulet O., Fournet J. C., Ricour C. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr: 2000; 24 6 345 350
5. Shin J. I., Namgung R., Park M. S., Lee C. Could lipid infusion be a risk for parenteral nutrition-associated cholestasis in low birth weight neonates? Eur J Pediatr: 2008; 167 2 197 202
6. Clayton P. T., Bowron A., Mills K. A., Massoud A., Casteels M., Milla P. J. Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology: 1993; 105 6 1806 1813
7. Javid P. J., Malone F. R., Dick A. A., et al. A contemporary analysis of parenteral nutrition-associated liver disease in surgical infants. J Pediatr Surg: 2011; 46 10 1913 1917
8. Beath S. V., Davies P., Papadopoulou A., et al. Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors. J Pediatr Surg: 1996; 31 4 604 606
9. Schulman J., Stricof R., Stevens T. P., et al. New York State Regional Perinatal Care Centers. Statewide NICU central-line-associated bloodstream infection rates decline after bundles and checklists. Pediatrics: 2011; 127 3 436 444
10. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics: 2004; 114 1 297 316
11. Teitelbaum D. H., Han-Markey T., Drongowski R. A., et al. Use of cholecystokinin to prevent the development of parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr: 1997; 21 2 100 103
12. Fok T. F., Chui K. K., Cheung R., Ng P. C., Cheung K. L., Hjelm M. Manganese intake and cholestatic jaundice in neonates receiving parenteral nutrition: a randomized controlled study. Acta Paediatr: 2001; 90 9 1009 1015
13. Koletzko B., Goulet O., Hunt J., Krohn K., Shamir R.; Parenteral Nutrition Guidelines Working Group; European Society for Clinical Nutrition and Metabolism; European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN); European Society of Paediatric Research (ESPR). 1. Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr: 2005; 41 02 S1 S87
14. La Scala G. C., Le Coultre C., Roche B. G., Bugmann P., Belli D. C. The addition of lipids increases the total parenteral nutrition-associated cholestasis in the rat. Eur J Pediatr Surg: 1993; 3 4 224 227
15. Haynes M. J., Stahlman M. T., Bradley Y. A., Jacqueline C. J. Hepatic pathology in extremely low birth weight baboons receiving long term intralipid. Pediatr Res: 2002; 1672A
16. Cavicchi M., Beau P., Crenn P., Degott C., Messing B. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med: 2000; 132 7 525 532
17. Hsieh M. H., Pai W., Tseng H. I., Yang S. N., Lu C. C., Chen H. L. Parenteral nutrition-associated cholestasis in premature babies: risk factors and predictors. Pediatr Neonatol: 2009; 50 5 202 207
18. Steinbach M., Clark R. H., Kelleher A. S., et al. Pediatrix Amino-Acid Study Group. Demographic and nutritional factors associated with prolonged cholestatic jaundice in the premature infant. J Perinatol: 2008; 28 2 129 135
19. Cober M. P., Teitelbaum D. H. Prevention of parenteral nutrition-associated liver disease: lipid minimization. Curr Opin Organ Transplant: 2010; 15 3 330 333
20. Hallikainen M., Huikko L., Kontra K., et al. Effect of parenteral serum plant sterols on liver enzymes and cholesterol metabolism in a patient with short bowel syndrome. Nutr Clin Pract: 2008; 23 4 429 435
21. Carter B. A., Shulman R. J. Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis. Nat Clin Pract Gastroenterol Hepatol: 2007; 4 5 277 287
22. Carter B. A., Taylor O. A., Prendergast D. R., et al. Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr Res: 2007; 62 3 301 306
23. Neuzil J., Darlow B. A., Inder T. E., Sluis K. B., Winterbourn C. C., Stocker R. Oxidation of parenteral lipid emulsion by ambient and phototherapy lights: potential toxicity of routine parenteral feeding. J Pediatr: 1995; 126 5 Pt 1 785 790
24. Baird L. L. Protecting TPN and lipid infusions from light: reducing hydroperoxides in NICU patients. Neonatal Netw: 2001; 20 2 17 22
25. Gura K. M., Lee S., Valim C., et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics: 2008; 121 3 e678 e686
26. Park K. T., Nespor C., Kerner J. Jr. The use of Omegaven in treating parenteral nutrition-associated liver disease. J Perinatol: 2011; 31 01 S57 S60
27. Puder M., Valim C., Meisel J. A., et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg: 2009; 250 3 395 402
28. Grimminger F., Wahn H., Mayer K., Kiss L., Walmrath D., Seeger W. Impact of arachidonic versus eicosapentaenoic acid on exotonin-induced lung vascular leakage: relation to 4-series versus 5-series leukotriene generation. Am J Respir Crit Care Med: 1997; 155 2 513 519
29. Wanten G. J., Calder P. C. Immune modulation by parenteral lipid emulsions. Am J Clin Nutr: 2007; 85 5 1171 1184
30. Beale E. F., Nelson R. M., Bucciarelli R. L., Donnelly W. H., Eitzman D. V. Intrahepatic cholestasis associated with parenteral nutrition in premature infants. Pediatrics: 1979; 64 3 342 347
31. Puligandla P. S., Janvier A., Flageole H., Bouchard S., Mok E., Laberge J. M. The significance of intrauterine growth restriction is different from prematurity for the outcome of infants with gastroschisis. J Pediatr Surg: 2004; 39 8 1200 1204
32. Balistreri W. F. Immaturity of hepatic excretory function and the ontogeny of bile acid metabolism. J Pediatr Gastroenterol Nutr: 1983; 2 01 S207 S214
33. Aynsley-Green A. Hormones and postnatal adaptation to enteral nutrition. J Pediatr Gastroenterol Nutr: 1983; 2 3 418 427
34. Clark R. H., Chace D. H., Spitzer A. R.; Pediatrix Amino Acid Study Group. Effects of two different doses of amino acid supplementation on growth and blood amino acid levels in premature neonates admitted to the neonatal intensive care unit: a randomized, controlled trial. Pediatrics: 2007; 120 6 1286 1296
35. Vileisis R. A., Inwood R. J., Hunt C. E. Prospective controlled study of parenteral nutrition-associated cholestatic jaundice: effect of protein intake. J Pediatr: 1980; 96 5 893 897
36. Costa S., Maggio L., Sindico P., Cota F., De Carolis M. P., Romagnoli C. Preterm small for gestational age infants are not at higher risk for parenteral nutrition-associated cholestasis. J Pediatr: 2010; 156 4 575 579
37. Sondheimer J. M., Asturias E., Cadnapaphornchai M. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr: 1998; 27 2 131 137